Search

everythinglearnresearchcommunity

for

Search:↓

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

Most pregnant women experience skin darkening and hair changes, with these effects usually going away after giving birth.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

Hair growth slows and shedding increases after childbirth, but most women don't experience excessive hair loss.

FPHL common in Taiwanese women; risk factors include BMI, high glucose, early puberty, fewer childbirths, oral contraceptives, and UV exposure.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

SACUMAN, a rare condition causing hair loss without clear signs, is often misdiagnosed and needs scalp biopsies for accurate detection.

Some antiandrogens may lower testosterone better than others, but it's unclear which is best for feminization in transgender women; more research is needed.

Higher early lead exposure is linked to delayed puberty in girls.

Hormone therapies like birth control pills and spironolactone are safe and effective for treating women's adult acne.

Finasteride may help some women with hair loss, but better options exist.

Hormone therapy can improve mental health and quality of life for people with gender dysphoria, but long-term effects need more research.

Women have a higher risk of blood clots from hormonal factors and need careful treatment, especially during pregnancy.

Cooler scalp temperatures during chemotherapy may prevent hair loss.

Preventive measures and effective management are crucial for reducing skin side effects in cancer treatment.

Alopecia areata patients have varied cancer risks, with some cancers being lower and others higher.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Hirsutism is common body hair growth due to genetics and hormones, and while not a disease, it can be distressing; virilisation includes hirsutism with other male traits and needs medical attention.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Babies who gain weight quickly, especially in the first 3 months, may start puberty earlier.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Women who had cancer treatment feel both positive and negative about their bodies.

Japanese infants fed hydrolysate formula may have low biotin levels.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

KLF4 is important for maintaining stem cells and has potential in cancer treatment and wound healing.

Testosterone patches can modestly improve sexual function in postmenopausal women not on estrogen therapy.

ATP-sensitive K+ channel subunits, particularly Sur2A, play a significant role in various cancers.

Misbehaving hair follicle stem cells can cause hair loss and offer new treatment options.

Precocious puberty is starting earlier due to factors like obesity and chemicals, with treatment focusing on preserving height and addressing social issues.